- |||||||||| indomethacin / Generic mfg., naproxen / Generic mfg., celecoxib oral / Generic mfg.
Journal: Celecoxib and naproxen disrupt autophagy and activate EGR1 in kidney tubules. (Pubmed Central) - Dec 11, 2025 Our study reveals dose-dependent tubulotoxic effects of NSAIDs unrelated to their COX-selectivity, suggesting an interplay between pro-fibrotic transcription factor EGR1, autophagy pathways and oxidative stress. These findings underscore the need for meticulous dose optimization especially in kidney disease patients in order to reduce nephrotoxicity.
- |||||||||| pentoxifylline / Generic mfg.
Review, Journal: Role of brain-gut axis in mechanism of gastrointestinal defense. (Pubmed Central) - Dec 9, 2025 Pharmacological agents, affecting mucosal blood flow, such as cyclooxygenase (COX) products, COX inhibitors and pentoxifylline, are also able to modify functions of the brain-gut axis. We conclude that brain-gut axis plays a particularly important role in maintaining of mucosal barrier in GI-tract and alteration in its functions is implicated in pathogenesis of various diseases of the gut.
- |||||||||| Journal: Trans-cinnamaldehyde alleviates IFN-?-induced depressive-like behaviors by restoring astrocytic Cx43 gap junction. (Pubmed Central) - Nov 21, 2025
Crucially, astrocyte-specific Cx43 knockout (Gfap-Cre; Cx43fl/fl) mice exhibited depression-like phenotypes and hyperactivated neuroinflammation, abolishing TCA's therapeutic effects. These results demonstrate that TCA mitigates IFN-?-induced depression by modulating astrocytic Cx43 gap junctions and inhibiting COX-2/NF-?B-driven neuroinflammation, positioning it as a novel immunopharmacological agent for inflammation-associated depression and highlighting Cx43 as a potential therapeutic target.
- |||||||||| Journal: Cyanide overproduction impairs cellular bioenergetics in Down syndrome. (Pubmed Central) - Nov 19, 2025
Cyanide and H2S may act cooperatively on the same molecular target. These results open the possibility of developing therapeutic strategies that target cyanide or both cyanide and H2S to counteract DS-associated metabolic impairment.
- |||||||||| caffeine citrate / Generic mfg.
Journal: Caffeine-Associated Reduction in Patent Ductus Arteriosus (PDA) is Mediated in Part by Adenosine Receptor Antagonism. (Pubmed Central) - Nov 19, 2025 Pressure myography was used to examine responses of the isolated ductus to adenosine, caffeine (citrate or base), or preincubation with either caffeine or adenosine...In conclusion, caffeine did not induce direct ductus constriction ex vivo. However, caffeine exposure prevented adenosine-induced ductus relaxation, suggesting inhibition of an endogenous vasodilator as a mechanism for reduction in PDA.
- |||||||||| flurbiprofen / Generic mfg., ibuprofen / Generic mfg.
Journal: Novel Ruthenacarborane-NSAID Conjugates. (Pubmed Central) - Nov 13, 2025 Notably, the conjugates demonstrated low COX inhibition and no cytotoxic potential against different cancer cell lines, probably due to oxidative deactivation confirmed by cyclic voltammetry (CV). This indicates that the conjugation of this type of ruthenacarborane with NSAIDs does not result in novel anticancer drugs.
- |||||||||| Journal: A Cautionary Tale: Non-steroidal anti-inflammatory drug use and localized provoked vulvodynia. (Pubmed Central) - Nov 12, 2025
PERSPECTIVE: Taking NSAIDs to manage chronic vulvar pain may downregulate levels of specialized pro-resolving lipid mediators, thereby resulting in prolonged pain and delayed inflammation resolution. This study provides one possible explanation for clinical reports of the ineffectiveness of NSAIDs in the mitigation of vulvodynia-associated pain.
- |||||||||| PK/PD data, Journal: Pharmacokinetics of carprofen in Siamese crocodiles (Crocodylus siamensis). (Pubmed Central) - Nov 12, 2025
These findings indicate sustained systemic exposure and high bioavailability of CAR in C. siamensis, supporting its potential as a long-acting analgesic. Future studies should assess pharmacodynamic responses and therapeutic efficacy in clinical settings to optimize dosing regimens.
- |||||||||| dexamethasone / Generic mfg.
Journal: Enhanced corneal permeation of diclofenac through an ophthalmic nanocrystal suspension. (Pubmed Central) - Nov 2, 2025 Clinical studies show it provides anti-inflammatory benefits comparable to dexamethasone but with a lower risk of increasing intraocular pressure...In summary, the developed nanosuspensions offer a promising strategy for improving DCF ocular delivery and therapeutic efficacy. Further clinical studies are needed to confirm long-term safety and effectiveness in humans.
- |||||||||| Journal: Antimicrobial effects and mechanisms of hydrogen sulphide against nail pathogens. (Pubmed Central) - Nov 1, 2025
COX inhibition likely causes electron leakage, generating ROS and oxidising cysteine residues, which then react with H2S to form S-sulfhydrated proteins. This novel mechanism, along with the ability of H2S to penetrate the nail, suggests topical delivery of an H2S donor is a promising new treatment for onychomycosis.
- |||||||||| Review, Journal: Traditional Applications, Phytochemical Constituents, and Pharmacological Properties of Lavandula multifida L.: A Review. (Pubmed Central) - Oct 16, 2025
This review concludes by identifying key research priorities for L. multifida, including a detailed analysis of its non-volatile compounds, mechanistic elucidation, toxicological assessments, and standardization of extracts. Addressing these gaps is essential to validate its traditional applications and advance its development into evidence-based phytomedicines, adjuvant therapies, and natural agrochemicals.
- |||||||||| indomethacin / Generic mfg.
Pharmacologically-induced neurovascular uncoupling in rats: model development challenges and insights (Poster Area; In-person) - Oct 10, 2025 - Abstract #ECNP2025ECNP_1436; In the current study, we employed a translationally relevant cohort of aged (~27.5 months old), cognitively experienced Long Evans rats (n=25). The three inhibitors were combined into a single-solution ("cocktail") and administered intraperitoneally twice daily for 14 days at individually tailored dosages.
- |||||||||| ibuprofen / Generic mfg.
Journal: Hybrid Conjugates of Ibuprofen and 3,5-Diarylidene-4-Piperidone: A New Avenue in Anti-Inflammatory Drug Discovery. (Pubmed Central) - Oct 7, 2025 Computational studies, including molecular docking and ADME (absorption, distribution, metabolism, and excretion) analyses, are performed to clarify the mechanisms of action and to predict pharmacokinetic properties. The findings indicate that some hybrid conjugates display promising anti-inflammatory properties, necessitating further investigation for their potential therapeutic applications.
- |||||||||| naproxen / Generic mfg., celecoxib oral / Generic mfg.
Journal: Nitrogen Monoxide Releasing Nitric Ester Derivatives of Ibuprofen and Naproxen as COX Inhibitors, Anti-Inflammatory and Hypolipidemic Compounds. (Pubmed Central) - Sep 27, 2025 In conclusion, the performed structural modifications resulted not only in the improvement of the anti-inflammatory activity, compared with the parent NSAID, but also acquired strong hypolipidemic activity. Thus, the combination of structural characteristics resulting in a decrease in lipidemia, with possible inhibition of atherosclerosis, due to their anti-inflammatory activity and vasodilatation ability, via the liberated NO, may constitute a useful rationale for new compounds.
- |||||||||| aspirin / Generic mfg., ibuprofen / Generic mfg., naproxen / Generic mfg.
Retrospective data, Journal, Adverse events: Pharmacovigilance Insights into Ibuprofen's Neuropsychiatric Safety: A Retrospective Analysis of EudraVigilance Reports. (Pubmed Central) - Sep 27, 2025 A limitation of the study can be noted as due to suspected causality, not an established one, and EV reports cannot accurately determine adverse drug reaction frequencies. Considering that ibuprofen is easily accessible as an OTC drug and the higher probability of reporting several neuropsychiatric adverse effects as shown by this study, patient counseling, when possible, and general education for the public are valuable tools in managing these adverse reactions.
- |||||||||| naproxen / Generic mfg.
Journal: Self-Assembling Hydrogels of Naproxen-Conjugated Peptides for Osteoarthritis Treatment. (Pubmed Central) - Sep 18, 2025 In vivo experiments demonstrate the NpxFFK hydrogel significantly mitigated articular degradation in OA rats, outperforming clinical treatments (naproxen treatment or hyaluronic acid treatment), thereby validating its therapeutic potential for OA. By integrating NSAID pharmacology with self-assembling peptide hydrogel delivery platform, we present a multifunctional strategy that significantly improves upon current OA treatments, underscoring its promise for translational healthcare innovation in OA management.
|